OP-15E - Risk of Diabetic Ketoacidosis with Sodium-glucose transporter-2 Inhibitors Compared to Dipeptidyl peptidase-4 (DPP4) Inhibitors and Sulfonylureas in Patients with Type 2 Diabetes
Location: OP-15
Safety End Points
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-25B - Cardiovascular Risk in Users of Mirabegron Relative to Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-interventional, Real-world Data Safety Study
Location: OP-25
Safety End Points
Tuesday, Aug 24th
1:45 PM - 3:30 PM US Eastern Time
OP-25C - Use of Low-dose Quetiapine and the Risk of Major Adverse Cardiovascular Events
Location: OP-25
Safety End Points
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP02F - The Risk of Seizures Associated with the Use of Tramadol: A Nationwide Case-case-time-control Study
Location: SP02
Safety End Points
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP03C - Incidence of Inpatient Constipation Among Migraine Patients Treated with Erenumab: A Retrospective Cohort Study in a US Electronic Health Record Database
Location: SP03
Safety End Points
Tuesday, Aug 24th
3:30 PM - 4:45 PM US Eastern Time
SP05G - Comparison of the Risk of Cardiovascular Outcomes in Novel Hormonal Agents in Metastatic Castration-resistant Prostate Cancer
Location: SP05
Safety End Points
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP10F - Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-based Screening Study
Location: SP10
Safety End Points
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP16A - Feasibility Assessment of Claims Databases for Pregnancy Outcomes
Location: SP16
Safety End Points
Tuesday, Aug 24th
5:15 PM - 6:30 PM US Eastern Time
SP17C - New-onset Autoimmune Disease (AID) Detection and Validation in Healthcare Databases
Location: SP17
Safety End Points
Tuesday, Aug 24th
6:45 PM - 7:45 PM US Eastern Time
L-3N - The Risk of Melanoma with Rasagiline Compared with Other Antiparkinsonian Medications: A Retrospective Cohort Study in the United States Medicare Database
Location: L-3
Safety End Points
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-1A - Proton Pump Inhibitors and Risk of Gastric Cancer: A Population-based Cohort Study
Location: OP-01
Safety End Points
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-1C - Comparative Safety of Conjugated Estrogens/bazedoxifene (CE/BZA) versus Estrogen/progestin Combination Hormone Therapy (EP): A Multi-database Cohort Study
Location: OP-01
Safety End Points
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-1E - Vitamin K Antagonists and Risk of Myelodysplastic Syndrome: A Nationwide Cohort Study in Atrial Fibrillation Patients
Location: OP-01
Safety End Points
Wednesday, Aug 25th
4:30 PM - 6:00 PM US Eastern Time
OP-1F - Use of Proton Pump Inhibitors and Risk of Pancreatic Adenocarcinoma: A Case-control Study Based on the French National Health Data System (SNDS)
